Pre Clinical Discovery Core

临床前发现核心

基本信息

  • 批准号:
    10678837
  • 负责人:
  • 金额:
    $ 18.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-01 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

Summary The preclinical studies are necessary for target identification and validation, for testing mechanistic hypotheses, and for initial proof-of-concept studies in appropriate pre-clinical animal models and represent an essential pre-requisite for advancing function promoting therapies (FPTs) to human trials. An important aspect of translational research in model organisms is the underlying assertion that the physiological processes that are evaluated in animal models are sufficiently similar to conditions observed in humans to allow dose and effect extrapolation. Additionally, for the outcomes of preclinical studies to be meaningfully interpreted, measurements must be reproducible, accurate, and sufficiently similar to the conditions observed in humans. Accordingly, the Boston OAIC has established a Preclinical Discovery Core that offers standardized procedures and state-of-the-art equipment for the analysis of muscle performance and physical function, muscle bioenergetics, and non-invasive imaging and whole body metabolic outcomes. The PDC provides standardized, state-of-the-art methods and instruments to assess body composition (lean body mass, whole body and regional fat mass, skeletal muscle mass, functional microscopy of the muscle using high resolution magnetic resonance imaging) in animal models of aging and disease to quantify outcomes in response to function promoting therapies. The PDC also offers consultative services to early career investigators to optimize study design, and guide the selection of appropriate experimental model and outcome measures. The PDC has established standardized procedures for training and certification of its staff involved, and for maintaining strict quality control in its procedures. The standard operating procedures have been approved by the IACUCs of the participating institutions to enable streamlined transfer of animals from the participating laboratory to the PDC facility. The PDC continues to innovate and provide novel measurement modalities to facilitate FPT discovery. The PDC leadership has worked closely with equipment manufacturers to continually refine the methods and improve the temporal resolution (signal to noise ratio), precision, and sensitivity of the techniques that it offers. The proposed developmental project will apply an ultra-high-field 7-tesla Magnetic Resonance Spectroscopy (MRS) method for the non-invasive measurement of NAD+/NADH in the skeletal muscle and brain enabling an in vivo assessment of mitochondrial efficiency without a tissue biopsy. The PDC has become a unique resource for OAIC-funded REC and PESC projects, and for externally-funded OAIC projects that are using preclinical models for FPT discovery research. The PDC supported studies have facilitated several successful NIH grant submissions and peer reviewed publications by OAIC investigators.
总结 临床前研究对于靶点的识别和验证、机理的检测和治疗是必要的。 假设,并在适当的临床前动物模型中进行初步概念验证研究,并代表 将功能促进疗法(FPT)推进到人体试验的基本先决条件。一个重要方面 在模式生物的转化研究是基本的主张,生理过程, 在动物模型中进行评价时,与在人体中观察到的情况足够相似, 效果外推此外,为了对临床前研究的结果进行有意义的解释, 测量必须是可再现的、准确的,并且与在人类中观察到的条件足够相似。 因此,波士顿OAIC建立了临床前发现核心,提供标准化的 用于分析肌肉性能和身体功能的程序和最先进的设备, 肌肉生物能量学、非侵入性成像和全身代谢结果。PDC提供 标准化的、最先进的方法和仪器来评估身体成分(瘦体重、整体 身体和局部脂肪量,骨骼肌质量,使用高分辨率的肌肉功能显微镜 磁共振成像),以量化响应于 功能促进疗法。PDC还为早期职业调查人员提供咨询服务, 优化研究设计,指导选择合适的实验模型和结局指标。 PDC已经制定了培训和认证相关工作人员的标准化程序, 在其程序中保持严格的质量控制。标准作业程序已获得批准, 参与机构的动物中心,以便从参与机构 实验室到PDC设施。PDC继续创新并提供新的测量模式, 促进FPT发现。PDC领导层与设备制造商密切合作, 改进方法,提高时间分辨率(信噪比)、精度和灵敏度, 它提供的技术。拟议的发展项目将采用超高场7特斯拉磁 用于骨骼肌中NAD+/NADH的非侵入性测量的共振光谱(MRS)方法 肌肉和脑,使得能够在没有组织活检的情况下体内评估线粒体效率。 PDC已成为OAIC资助的REC和PESC项目以及外部资助项目的独特资源。 使用临床前模型进行FPT发现研究的OAIC项目。PDC支持的研究包括 协助OAIC研究人员成功提交了几份NIH资助申请和同行评审的出版物。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ravi Jasuja其他文献

Ravi Jasuja的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ravi Jasuja', 18)}}的其他基金

Preclinical Characterization of Novel Formulation for Sustained Testosterone Delivery
持续睾酮输送新制剂的临床前表征
  • 批准号:
    10043400
  • 财政年份:
    2020
  • 资助金额:
    $ 18.62万
  • 项目类别:
Preclinical Characterization of Novel Formulation for Sustained Testosterone Delivery
持续睾酮输送新制剂的临床前表征
  • 批准号:
    10408172
  • 财政年份:
    2020
  • 资助金额:
    $ 18.62万
  • 项目类别:
Preclinical Characterization of Novel Formulation for Sustained Testosterone Delivery
持续睾酮输送新制剂的临床前表征
  • 批准号:
    10251874
  • 财政年份:
    2020
  • 资助金额:
    $ 18.62万
  • 项目类别:
Novel Algorithm for Free Testosterone Determination
游离睾酮测定的新算法
  • 批准号:
    8647313
  • 财政年份:
    2014
  • 资助金额:
    $ 18.62万
  • 项目类别:
Phase IIB: Development of TruT Algorithm for Commercialization in Androgen Disorders
IIB 期:用于雄激素疾病商业化的 TruT 算法的开发
  • 批准号:
    10707198
  • 财政年份:
    2014
  • 资助金额:
    $ 18.62万
  • 项目类别:
Phase IIB: Development of TruT Algorithm for Commercialization in Androgen Disorders
IIB 期:用于雄激素疾病商业化的 TruT 算法的开发
  • 批准号:
    10603887
  • 财政年份:
    2014
  • 资助金额:
    $ 18.62万
  • 项目类别:
Pre Clinical Discovery Core
临床前发现核心
  • 批准号:
    10293912
  • 财政年份:
    2008
  • 资助金额:
    $ 18.62万
  • 项目类别:
LIGAND-INDUCED CONFORMATIONAL DYNAMICS IN ANDROGEN RECEPTOR & CO-ACTIVATORS
雄激素受体中配体诱导的构象动力学
  • 批准号:
    7724075
  • 财政年份:
    2008
  • 资助金额:
    $ 18.62万
  • 项目类别:
Pre Clinical Discovery Core
临床前发现核心
  • 批准号:
    10470356
  • 财政年份:
    2008
  • 资助金额:
    $ 18.62万
  • 项目类别:
Preclinical Discovery Core
临床前发现核心
  • 批准号:
    9170588
  • 财政年份:
  • 资助金额:
    $ 18.62万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 18.62万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 18.62万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 18.62万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 18.62万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 18.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 18.62万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 18.62万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 18.62万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 18.62万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 18.62万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了